Law firm investigating Citius Oncology, Inc. (NASDAQ: CTOR) on behalf of shareholders to review possible breach of fiduciary duty.

Unusual Whales
2026.01.05 15:32
In New York on January 5, 2026, the law firm Purcell & Lefkowitz LLP disclosed its investigation into Citius Oncology, Inc. (NASDAQ: CTOR) for the benefit of the shareholders. This inquiry aims to assess whether the directors of Citius Oncology may have violated their fiduciary responsibilities towards the company and its stakeholders.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2026 Longbridge｜Disclaimer